Xenon Pharmaceuticals Inc.(XENE)
Pharmaceuticals
CNS / Psychiatry Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | PATOU GARY Director | Sale | -1,322 | -0.86%152,327 | $53.14 | $70,251 | View SEC filing | |
| 2026-06-08 | Cannon Gillian Director | Sale | -1,190 | -2.21%52,675 | $53.14 | $63,237 | View SEC filing | |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | -1,410 | -16.63%7,069 | $55.23 | $77,867 | View SEC filing | |
| 2026-03-13 | DiFabio Andrea Chief Legal Officer | Sale | -1,342 | -15.53%7,301 | $55.22 | $74,112 | View SEC filing | |
| 2026-03-13 | MORTIMER IAN PRESIDENT & CEO | Sale | -7,308 | -17.60%34,223 | $55.23 | $403,584 | View SEC filing | |
| 2026-03-11 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | -2,771 | -36.95%4,729 | $60.11 | $166,559 | View SEC filing | |
| 2026-03-11 | DiFabio Andrea Chief Legal Officer | Sale | -2,607 | -34.76%4,893 | $60.11 | $156,702 | View SEC filing | |
| 2026-03-11 | MORTIMER IAN PRESIDENT & CEO | Sale | -281,269 | -90.64%29,031 | $60.32 | $16,966,500 | View SEC filing | |
| 2026-01-02 | MORTIMER IAN PRESIDENT & CEO | Sale | -40,000 | -66.33%20,300 | $44.43 | $1,777,093 | View SEC filing | |
| 2025-12-09 | MORTIMER IAN PRESIDENT & CEO | Sale | -25,205 | -55.39%20,300 | $45.33 | $1,142,513 | View SEC filing | |
| 2025-12-03 | MORTIMER IAN PRESIDENT & CEO | Sale | -97 | -0.21%45,505 | $45.01 | $4,366 | View SEC filing | |
| 2025-10-01 | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | Sale | -25,000 | -35.41%45,602 | $40.16 | $1,004,000 | View SEC filing | |
| 2025-06-06 | GANNON STEVEN Director | Sale | -3 | -0.04%7,141 | $30.48 | $91 | View SEC filing | |
| 2025-01-27 | MORTIMER IAN PRESIDENT & CEO | Sale | -55,000 | -54.67%45,602 | $40.25 | $2,213,997 | View SEC filing | |
| 2024-12-19 | AULIN SHERRY Chief Financial Officer | Sale | -18,709 | -100.00%0 | $41.21 | $770,912 | View SEC filing | |
| 2024-11-22 | PATOU GARY Director | Sale | -4,891 | -14.66%28,475 | $41.08 | $200,947 | View SEC filing | |
| 2024-03-11 | GAROFALO ELIZABETH A. Director | Sale | -2,092 | -100.00%0 | $45.69 | $95,583 | View SEC filing | |
| 2024-03-08 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Sale | -7,137 | -45.94%8,398 | $46.28 | $330,290 | View SEC filing | |
| 2024-03-08 | GANNON STEVEN Director | Sale | -13,000 | -86.67%2,000 | $46.28 | $601,615 | View SEC filing | |
| 2023-12-15 | PATOU GARY Director | Sale | -7,598 | -60.78%4,902 | $41.05 | $311,898 | View SEC filing | |
| 2023-12-15 | PATOU GARY Director | Sale | -18,978 | -30.84%28,475 | $39.99 | $758,983 | View SEC filing | |
| 2023-08-24 | Svoronos Dawn Director | Sale | -25,000 | -50.00%25,000 | $38.70 | $967,500 | View SEC filing | |
| 2023-06-01 | PIMSTONE SIMON N. Director | Sale | -131,245 | -89.09%6,000 | $38.90 | $5,104,970 | View SEC filing | |
| 2023-05-26 | MORTIMER IAN PRESIDENT & CEO | Sale | -31,655 | -40.97%45,602 | $41.41 | $1,310,931 | View SEC filing | |
| 2023-03-24 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | -700 | -100.00%0 | $35.01 | $24,507 | View SEC filing |
1-25 of 69